Addition of trimethoprim-sulfamethoxazole to ceftazidime during parenteral treatment of melioidosis is not associated with a long-term outcome benefit [4]
Saved in:
Main Authors: | Wirongrong Chierakul, Siriluck Anunnatsiri, Wipada Chaowagul, Sharon J. Peacock, Ploenchan Chetchotisakd, Nicholas P. Day |
---|---|
Other Authors: | Mahidol University |
Format: | Letter |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/24784 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Two randomized controlled trials of ceftazidime alone versus ceftazidime in combination with trimethoprim-sulfamethoxazole for the treatment of severe melioidosis
by: Wirongrong Chierakul, et al.
Published: (2018) -
Dosing regimens of cotrimoxazole (trimethoprim-sulfamethoxazole) for melioidosis
by: Allen C. Cheng, et al.
Published: (2018) -
Open-label randomized trial of oral trimethoprim-sulfamethoxazole, doxycycline, and chloramphenicol compared with trimethoprim-sulfamethoxazole and doxycycline for maintenance therapy of melioidosis
by: Wipada Chaowagul, et al.
Published: (2018) -
Trimethoprim-sulfamethoxazole versus trimethoprimsulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): A multicentre, double-blind, non-inferiority, randomised controlled trial
by: Ploenchan Chetchotisakd, et al.
Published: (2018) -
A Comparison Between 12 Versus 20 Weeks of Trimethoprim-sulfamethoxazole as Oral Eradication Treatment for Melioidosis: An Open-label, Pragmatic, Multicenter, Non-inferiority, Randomized Controlled Trial
by: Siriluck Anunnatsiri, et al.
Published: (2022)